- Home
- IMTX vs MAX Comparison
IMTX vs MAX Comparison
Compare IMTX & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- MAX
- Stock Information
- Founded
- IMTX N/A
- MAX 2014
- Country
- IMTX Germany
- MAX United States
- Employees
- IMTX N/A
- MAX N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- MAX Industrial Machinery/Components
- Sector
- IMTX Health Care
- MAX Industrials
- Exchange
- IMTX Nasdaq
- MAX Nasdaq
- Market Cap
- IMTX 579.8M
- MAX 582.4M
- IPO Year
- IMTX N/A
- MAX 2020
- Fundamental
- Price
- IMTX $5.71
- MAX $10.50
- Analyst Decision
- IMTX Strong Buy
- MAX Strong Buy
- Analyst Count
- IMTX 4
- MAX 6
- Target Price
- IMTX $14.67
- MAX $17.92
- AVG Volume (30 Days)
- IMTX 773.0K
- MAX 412.1K
- Earning Date
- IMTX 08-12-2025
- MAX 07-30-2025
- Dividend Yield
- IMTX N/A
- MAX N/A
- EPS Growth
- IMTX N/A
- MAX N/A
- EPS
- IMTX N/A
- MAX 0.28
- Revenue
- IMTX $155,801,989.00
- MAX $1,002,364,000.00
- Revenue This Year
- IMTX N/A
- MAX $24.09
- Revenue Next Year
- IMTX $1.92
- MAX $11.18
- P/E Ratio
- IMTX N/A
- MAX $37.89
- Revenue Growth
- IMTX 93.56
- MAX 148.62
- 52 Week Low
- IMTX $3.30
- MAX $7.33
- 52 Week High
- IMTX $13.09
- MAX $20.91
- Technical
- Relative Strength Index (RSI)
- IMTX 55.46
- MAX 47.66
- Support Level
- IMTX $5.23
- MAX $10.39
- Resistance Level
- IMTX $5.82
- MAX $11.19
- Average True Range (ATR)
- IMTX 0.28
- MAX 0.35
- MACD
- IMTX -0.05
- MAX -0.08
- Stochastic Oscillator
- IMTX 43.48
- MAX 14.72
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About MAX MediaAlpha Inc.
MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.